May 11th: CO-nquering COVID-19 teaching challenges

Objectives

Following the presentation, attendees will be able to:

1.     Identify challenges in creating successful remote didactic and experiential learning opportunities
2.     Describe classroom and experiential innovations that have emerged during this global pandemic 
3.     Discuss ways to involve our didactic and experiential learners in processing the wave of new evidence

Continuing Education credits will be available soon 

 

 

Presenters

Heather Blue, PharmD, BCPS, BCGP, Assistant Professor of Clinical Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences and Emergency Medicine Pharmacist at St. Luke's Hospital

Scott A. Chapman, PharmD, Associate Professor, Department of Experimental & Clinical Pharmacology

Betsy Hirsch, PharmD, RPh, Assistant Professor, Department of Experimental & Clinical Pharmacology

Diana Langworthy, PharmD, BCPS, Assistant Professor, Department of Pharmaceutical Care & Health Systems and Clinical Pharmacist, Internal Medicine, UMMC

 

Disclosure Statements

The University of Minnesota, College of Pharmacy has a conflict of interest policy that requires course faculty to disclose whether they have financial interests or affiliations with organizations with a direct substantial interest in the subject matter of their programs. The following information was received from Drs. Blue, Chapman, Hirsch and Langworthy.

Heather Blue, PharmD, BCPS, BCGP
No relationships to disclose. Dr. Blue will not discuss off-label or investigational uses of commercial products.

Scott Chapman, PharmD
No relationships to disclose. Dr. Chapman will not discuss off-label or investigational uses of commercial products.

Betsy Hirsch, PharmD, RPh
Dr. Hirsch is a consultant for Nabriva and has received grant/research support from Merck. Dr. Hirsch discusses off-label use of investigational agents for SARS-CoV-2, remdesivir, and hydroxychloroquine/chloroquine.  

Diana Langworthy, PharmD, BCPS
No relationships to disclose. Dr. Langworthy will not discuss off-label or investigational uses of commercial products.